Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Conversion from nuclear bilobation to indentation in BCR/ABL1-positive acute myeloid leukemia lacking CD34 and HLA-DR expression.

Yamamoto K, Yakushijin K, Sanada Y, Kawamoto S, Nakamachi Y, Kawano S, Matsuoka H, Minami H.

Ann Hematol. 2015 Jan;94(1):177-9. doi: 10.1007/s00277-014-2133-x. Epub 2014 Jun 13. No abstract available.

PMID:
24923453
2.
3.

Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

Kroschinsky FP, Schäkel U, Fischer R, Mohr B, Oelschlaegel U, Repp R, Schaich M, Soucek S, Baretton G, Ehninger G, Thiede C; DSIL (Deutsche Studieninitiative Leukämie) Study Group.

Haematologica. 2008 Feb;93(2):283-6. doi: 10.3324/haematol.11669. Epub 2008 Jan 26.

4.
5.

Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.

Misawa M, Maeda H, Hara H, Yamamoto Y, Furuyama J.

Stem Cells. 1993 Nov;11(6):536-42.

PMID:
7509222
6.

[Detection of BCR-ABL1 chimeric gene-positive neutrophils in a patient with mixed phenotype acute leukemia].

Nagasawa F, Nakamura Y, Tokita K, Takahashi W, Iso H, Arai H, Tsurumi S, Handa T, Nakamura Y, Nakamura Y, Sasaki K, Mitani K.

Rinsho Ketsueki. 2013 Nov;54(11):2074-8. Japanese.

PMID:
24305542
7.

BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.

Grand FH, Marley SB, Chase A, Titley I, Healy L, Spencer A, Reiter A, Goldman JM, Gordon MY.

Leukemia. 1997 Sep;11(9):1486-92.

PMID:
9305602
8.

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G.

Blood. 2009 Sep 3;114(10):2159-67. doi: 10.1182/blood-2008-08-173963. Epub 2009 Jul 9. Erratum in: Blood. 2010 Sep 23;116(12):2196.

9.

Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.

Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R.

Blood. 1993 Feb 1;81(3):801-7.

10.
11.

Near-hexaploid Ph-positive acute myeloid leukemia with major-BCR/ABL transcript.

Iwama H, Ohyashiki K, Ohyashiki JH, Shimamoto T, Fujimura T, Kawakubo K, Kuriyama Y, Kodama A, Toyama K.

Cancer Genet Cytogenet. 1996 Jan;86(1):61-4.

PMID:
8616789
12.

Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.

Ferrari A, Bussaglia E, Úbeda J, Facchini L, Aventin A, Sierra J, Nomdedéu JF.

Hematol Oncol. 2012 Sep;30(3):109-14. doi: 10.1002/hon.1011. Epub 2011 Aug 3.

PMID:
21812014
13.

Enrichment of normal progenitors in counter-flow centrifugal elutriation (CCE) fractions of fresh chronic myeloid leukemia leukapheresis products.

Dlubek D, Dybko J, Wysoczanska B, Laba A, Klimczak A, Kryczek I, Konopka L, Lange A.

Eur J Haematol. 2002 May;68(5):281-8.

PMID:
12144534
14.

Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.

Sindt A, Deau B, Brahim W, Staal A, Visanica S, Villarese P, Rault JP, Macintyre E, Delabesse E.

Genes Chromosomes Cancer. 2006 Jun;45(6):575-82.

PMID:
16518848
15.

IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+ hematopoietic cells on stromal cells.

Suzuki K, Ono R, Ohishi K, Masuya M, Kataoka I, Liu B, Nakamori Y, Ino K, Monma F, Hamada H, Kitamura T, Katayama N, Nosaka T.

Int J Oncol. 2012 Jan;40(1):53-62. doi: 10.3892/ijo.2011.1192. Epub 2011 Sep 7.

PMID:
21901249
16.
17.

BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response.

Simara P, Peterkova M, Stejskal S, Potesilova M, Koutna I, Racil Z, Razga F, Jurcek T, Dvorakova D, Mayer J.

Leuk Lymphoma. 2012 Aug;53(8):1627-9. doi: 10.3109/10428194.2012.656104. Epub 2012 Mar 1. No abstract available.

PMID:
22233112
18.

[Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome].

Kakihana K, Mizuchi D, Yamaguchi M, Sakashita C, Fukuda T, Yamamoto K, Miki T, Murakami N, Miura O.

Rinsho Ketsueki. 2003 Apr;44(4):242-8. Review. English, Japanese.

PMID:
12784657
19.

[The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].

Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.

Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):98-103. Chinese.

PMID:
23611213
20.

Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.

Koldehoff M, Steckel NK, Beelen DW, Elmaagacli AH.

Clin Exp Med. 2006 Mar;6(1):45-7. No abstract available.

PMID:
16550344

Supplemental Content

Support Center